Key result
Higher pre-training serum calcium linked to ~39% greater CMVD odds per 1 mmol/L in high-altitude trainees.
Why the study?
Coronary microvascular disease is an emerging concern under high-altitude hypoxia, but data on modifiable correlates are scarce and the association between serum calcium and CMVD at high altitude has not been systematically examined.
Are higher pre-training serum calcium levels associated with an increased risk of coronary microvascular disease in adults undergoing high-altitude training?
Case-Control (n=1,175)
No
Are higher pre-training serum calcium levels associated with an increased risk of coronary microvascular disease in adults undergoing high-altitude training?
Higher pre-training serum calcium levels are independently associated with an increased risk of coronary microvascular disease during high-altitude exposure, suggesting its potential utility as a screening biomarker.
Caution against using calcium for CMD screening in trainees; hypothesis-generating association requires prospective validation.
Background Coronary microvascular disease (CMVD) is an emerging concern under high-altitude hypoxia, but data on modifiable correlates are scarce. Serum calcium regulates vascular tone and coagulation, making it a plausible candidate marker. However, its association with CMVD at high altitude has not been systematically examined. Methods This nested case-control study enrolled 1,175 participants undergoing high-altitude training at 3,000–3,500 m. Participants were classified into CMVD and non-CMVD groups based on electrocardiogram (ECG) screening and coronary flow reserve (CFR ≤ 2.3) confirmed by transthoracic Doppler echocardiography. Cases ( n = 235) were individuals with ECG ST-T abnormalities and reduced CFR, while controls ( n = 940) were randomly matched by age and sex from those without such abnormalities. Pre-training serum calcium (Ca 2+ ) levels, along with age, sex, body mass index (BMI), systolic blood pressure (SBP), oxygen saturation (OS), low-density lipoprotein cholesterol (LDL-C), smoking status, and SCOPA-AUT scores, were collected. Multivariable logistic regression was employed to evaluate the independent association between serum calcium and CMVD, adjusting for age, sex, BMI, SBP, and other covariates. Variance inflation factor (VIF < 7) was used to exclude multicollinearity. Results Serum calcium levels were significantly higher in the CMVD group than in the non-CMVD group [2.42 (2.32–2.47) vs. 2.37 (2.31–2.42) mmol/L, P < 0.001]. Multivariable logistic regression revealed that serum calcium was independently associated with CMVD (OR = 1.39, 95% CI: 1.20–1.61, P < 0.001), indicating that each 1 mmol/L increase in calcium was associated with a 39% higher odds of CMVD. Age (OR = 1.05, 95% CI: 1.02–1.09, P = 0.001), female sex (OR = 4.13, 95% CI: 1.44–11.89, P = 0.009), and SBP (OR = 1.02, 95% CI: 1.00–1.03, P = 0.009) were also independently associated with CMVD. Subgroup analyses showed consistent associations across most strata, except in underweight and obese BMI categories and former smokers. Conclusion In this nested case-control sample of high-altitude trainees, higher serum calcium levels were significantly associated with an increased prevalence of CMVD. These findings suggest that serum calcium may serve as a potential screening indicator for CMVD in high-altitude settings.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2026) conducted a case-control in Coronary microvascular disease (CMVD) (n=1,175). Serum calcium levels vs. Lower serum calcium levels was evaluated on Coronary microvascular disease (CMVD) (OR 1.39, 95% CI 1.20-1.61, p=<0.001). Higher pre-training serum calcium levels were independently associated with an increased prevalence of coronary microvascular disease in high-altitude trainees, with each 1 mmol/L increase associated with a 39% higher odds (OR 1.39).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: